An update on tinea capitis in children.
fungal infection
pediatric patients
ringworm of scalp
tinea capitis
Journal
Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799
Informations de publication
Date de publication:
07 Aug 2024
07 Aug 2024
Historique:
received:
29
04
2024
accepted:
07
07
2024
medline:
8
8
2024
pubmed:
8
8
2024
entrez:
8
8
2024
Statut:
aheadofprint
Résumé
Tinea capitis presents a significant public health care challenge due to its contagious nature, and potential long-term consequences if unrecognized and untreated. This review explores the prevalence, risk factors, diagnostic methods, prevention strategies, impact on quality of life, and treatment options for pediatric tinea capitis. Epidemiological analysis spanning from 1990 to 1993 and 2020 to 2023 reveals prevalence patterns of pediatric tinea capitis influenced by geographic, demographic, and environmental factors. Notably, Trichophyton species is most prevalent in North America; however, Microsporum species remain the primary causative agent globally, with regional variations. Risk factors include close contact and environmental conditions, emphasizing the importance of preventive measures. Accurate diagnosis relies on clinical evaluation, microscopic examination, and fungal culture. Various treatment modalities including systemic antifungals show efficacy, with terbinafine demonstrating superior mycological cure rates particularly for Trichophyton species. Recurrent infections and the potential development of resistance can pose challenges. Therefore, confirming the diagnosis, appropriately educating the patient/caregiver, accurate drug and dose utilization, and compliance are important components of clinical cure. Untreated or poorly treated tinea capitis can lead to chronic infection, social stigma, and psychological distress in affected children. Prevention strategies focus on early detection and healthy lifestyle habits. Collaborative efforts between healthcare providers and public health agencies are important in treating pediatric tinea capitis and improving patient outcomes. Education and awareness initiatives play a vital role in prevention and community-level intervention to minimize spread of infection. Future research should explore diagnostic advances, novel treatments, and resistance mechanisms in order to mitigate the disease burden effectively.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Pediatric Dermatology published by Wiley Periodicals LLC.
Références
Mayser P, Nenoff P, Reinel D, et al. S1 guidelines: Tinea capitis. J Dtsch Dermatol Ges. 2020;18(2):161‐179. doi:10.1111/DDG.14026
Klein EJ, Karim M, Kushner CJ, et al. Enlarging alopecic patch in an African American woman with central centrifugal cicatricial alopecia: a case of concomitant tinea incognito. JAAD Case Rep. 2022;23:67‐69. doi:10.1016/j.jdcr.2022.02.028
Silverberg NB, Weinberg JM, DeLeo VA. Tinea capitis: focus on African American women. J Am Acad Dermatol. 2002;46(2):S120‐S124. doi:10.1067/MJD.2002.120793
Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM. Tinea capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58‐68. doi:10.2174/1872213X14666200106145624
Wang X, Abuliezi R, Hasimu H, Zhang L, Abliz P. Retrospective analysis of tinea capitis in Xinjiang, China. Mycopathologia. 2023;188(5):523‐529. doi:10.1007/s11046‐022‐00702‐0
Birhanu MY, Temesgen H, Ketema DB, et al. Tinea capitis among schoolchildren in Ethiopia: a systematic review and meta analysis. PLoS One. 2023;18(2):e0280948. doi:10.1371/journal.pone.0280948
Fienemika AE, Okeafor CU. The identification and grading of the psychosocial impact of tinea capitis in primary school children in a semi‐urban area of Rivers state, Nigeria. Niger Postgrad Med J. 2017;24(1):20‐24. doi:10.4103/NPMJ.NPMJ_172_16
Chen XQ, Yu J. Global demographic characteristics and pathogen spectrum of tinea capitis. Mycopathologia. 2023;188(5):433‐447. doi:10.1007/S11046‐023‐00710‐8
Rodríguez‐Cerdeira C, Martínez‐Herrera E, Szepietowski JC, et al. A systematic review of worldwide data on tinea capitis: analysis of the last 20 years. J Eur Acad Dermatol Venereol. 2021;35(4):844‐883. doi:10.1111/JDV.16951
Zhan P, Li D, Wang C, et al. Epidemiological changes in tinea capitis over the sixty years of economic growth in China. Med Mycol. 2015;53(7):691‐698. doi:10.1093/MMY/MYV057
Dascalu J, Zaaroura H, Renert‐Yuval Y, Khamaysi Z, Avitan‐Hersh E, Friedland R. Pediatric tinea capitis: a retrospective cohort study from 2010 to 2021. J Fungi. 2023;9(3):366. doi:10.3390/jof9030366
Committee on Infectious Diseases AA of P. Tinea capitis (ringworm of the scalp). In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; 2021:755‐759.
Xiao YY, Bin ZY, Chao JJ, Ma L. Epidemiology of tinea capitis in children in Beijing and adjacent regions, China: a 15‐year retrospective study. Mycopathologia. 2023;188(5):531‐535. doi:10.1007/s11046‐022‐00649‐2
Dong B, Chen Y, Yu H, et al. Epidemiology and aetiology of tinea capitis in Wuhan and its surrounding areas from 2011 till the present: a single‐center retrospective study. Mycopathologia. 2023;188(5):479‐488. doi:10.1007/s11046‐023‐00732‐2
Cukierman E, Camargo TZS, Millan LPB, Freire MR, Carneiro LFM, Waksman RD. Alopecia and pet: a case report. Einstein. 2022;20:eRC6881. doi:10.31744/EINSTEIN_JOURNAL/2022RC6881
Zhou X, Liu W, Yang S, et al. Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases. Mycoses. 2023;66(4):338‐345. doi:10.1111/myc.13558
Zaraa I, Hawilo A, Aounallah A, et al. Inflammatory tinea capitis: a 12‐year study and a review of the literature. Mycoses. 2013;56(2):110‐116. doi:10.1111/J.1439‐0507.2012.02219.X
Heath CR, Usatine RP. Tinea capitis. Cutis. 2022;110(4):226‐227. doi:10.12788/CUTIS.0630
Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454‐463. doi:10.1111/BJD.13196
Ion A, Popa LG, Porumb‐Andrese E, et al. A current diagnostic and therapeutic challenge: tinea capitis. J Clin Med. 2024;13(2):376. doi:10.3390/JCM13020376
Gupta AK, Friedlander SF, Simkovich AJ. Tinea capitis: An update. Pediatr Dermatol. 2022;39(2):167‐172. doi:10.1111/PDE.14925
Meneses OM, Donati A, Silva FO, Mimiça MJ, Machado CJ, Veasey J. Trichoscopy patterns of tinea capitis and their correlation with mycological culture results. J Am Acad Dermatol. 2023;88(1):166‐167. doi:10.1016/J.JAAD.2021.12.010
Hay RJ. Tinea capitis: current status. Mycopathologia. 2017;182(1):87‐93. doi:10.1007/S11046‐016‐0058‐8
Theiler M, Luchsinger I, Rast AC, Schwieger‐Briel A, Weibel L, Bosshard PP. Precision diagnostics in paediatric dermatology: advancing management of tinea capitis through dermatophyte PCR. J Eu Acad Dermatol Venereol. 2024;31. doi:10.1111/jdv.20147
Wei L, Jun QJ Mini‐review: the diagnostic methods of tinea capitis. Mycopathologia. 2023;188(5):563‐569. doi:10.1007/S11046‐023‐00731‐3
Hubbard TW, De Triquet JM. Brush‐culture method for diagnosing tinea capitis. Pediatrics. 1992;90(3):416‐418.
Friedlander SF, Pickering B, Cunningham BB, Gibbs NF, Eichenfield LF. Use of the cotton swab method in diagnosing tinea capitis. Pediatrics. 1999;104(2):276‐279. doi:10.1542/PEDS.104.2.276
Müller VL, Kappa‐Markovi K, Hyun J, et al. Tinea capitis et barbae caused by trichophyton tonsurans: a retrospective cohort study of an infection chain after shavings in barber shops. Mycoses. 2021;64(4):428‐436. doi:10.1111/MYC.13231
Aharaz A, Jemec GBE, Hay RJ, Saunte DML. Tinea capitis asymptomatic carriers: what is the evidence behind treatment? J Eur Acad Dermatol Venereol. 2021;35(11):2199‐2207. doi:10.1111/JDV.17462
White JML, Higgins EM, Fuller LC. Screening for asymptomatic carriage of trichophyton tonsurans in household contacts of patients with tinea capitis: results of 209 patients from South London. J Eur Acad Dermatol Venereol. 2007;21(8):1061‐1064. doi:10.1111/J.1468‐3083.2007.02173.X
Mohta A, Singh A, Nyati A, et al. Evaluation of impact of tinea capitis on quality of life in pediatric patients using children's dermatology life quality index and its correlation with disease duration. Int J Trichol. 2020;12(5):213‐219. doi:10.4103/IJT.IJT_58_20
Abastabar M, Babaei M, Mohammadi R, et al. Iranian National Survey on tinea capitis: antifungal susceptibility profile, epidemiological characteristics, and report of two strains with a novel mutation in SQLE gene with homology modeling. Mycopathologia. 2023;188(5):449‐460. doi:10.1007/s11046‐022‐00657‐2
Elmas ÖF, Durdu M. Histopathology in the diagnosis of tinea capitis: when to do, how to interpret? Mycopathologia. 2023;188(5):545‐552. doi:10.1007/S11046‐023‐00711‐7
Le TK, Cohen BA. Tinea capitis: advances and a needed paradigm shift. Curr Opin Pediatr. 2021;33(4):387‐391. doi:10.1097/MOP.0000000000001034
Dyer J, Foy VM. Revealing the unseen: a review of Wood's lamp in dermatology. J Clin Aesthet Dermatol. 2022;15(6):25‐30.
Verrinder Veasey J, Arruda B, Miguel F, Bedrikow RB, Veasey JV. Wood's lamp in dermatology: applications in the daily practice. Surg Cosmet Dermatol. 2018;9(4):328. doi:10.5935/scd1984‐8773.201794964
Skaastrup KN, Astvad KMT, Arendrup MC, Jemec GBE, Saunte DML. Disinfection trials with terbinafine‐susceptible and terbinafine‐resistant dermatophytes. Mycoses. 2022;65(7):741‐746. doi:10.1111/MYC.13468
Akhoundi M, Nasrallah J, Marteau A, Chebbah D, Izri A, Brun S. Effect of household laundering, heat drying, and freezing on the survival of dermatophyte conidia. J Fungi. 2022;8(5):546. doi:10.3390/JOF8050546
Monod M, Fratti M, Mignon B, Baudraz‐Rosselet F. Dermatophytes transmitted by pets and cattle. Rev Med Suisse. 2014;10(424):749‐753.
Gupta AK, Hofstader SLR, Adam P, Summerbell RC. Tinea capitis: an overview with emphasis on management. Pediatr Dermatol. 1999;16(3):171‐189. doi:10.1046/J.1525‐1470.1999.00050.X
Gupta AK, Mays RR, Versteeg SG, et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol. 2018;32(12):2264‐2274. doi:10.1111/JDV.15088
US Food and Drug Administration. GRIS‐PEG® (Griseofulvin ultramicrosize) tablets, USP 125 MG; 250 MG Rx only (accessed May 30, 2024), 2016, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050475s057lbl.pdf.
US Food and Drug Administration. DIFLUCAN® (Fluconazole tablets) (Fluconazole for oral suspension), 2019 (accessed May 30, 2024), https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019949s065,020090s047lbl.pdf.
US Food and Drug Administration. LAMISIL® (Terbinafine hydrochloride) tablets, for oral use, 2019 (accessed May 30, 2024), https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf.
US Food and Drug Administration. LAMISIL® (terbinafine hydrochloride) oral granules, 125 mg and 187.5 mg. For oral use, 2013 (accessed May 30, 2024), https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022071s009lbl.pdf.
Patel D, Castelo‐Soccio LA, Rubin AI, Streicher JL. Laboratory monitoring during systemic terbinafine therapy for pediatric onychomycosis. JAMA Dermatol. 2017;153(12):1326‐1327. doi:10.1001/JAMADERMATOL.2017.4483
Wang Y, Lipner SR. Retrospective analysis of abnormal laboratory test results in pediatric patients prescribed terbinafine for superficial fungal infections. J Am Acad Dermatol. 2021;85(4):1042‐1044. doi:10.1016/J.JAAD.2021.01.073